Toll-like receptor 7 mediates early innate immune responses to malaria

Infection and Immunity

Volumn 81, Issue 12, 2013, Pages 4431-4442

  Baccarella, Alyssa ^a   Fontana, Mary F ^a   Chen, Eunice C ^a   Kim, Charles C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOSTIMULATION; INNATE IMMUNITY; MALARIA; MOUSE; NONHUMAN; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; IMMUNITY, INNATE; INTERFERON TYPE I; INTERFERON-GAMMA; INTERLEUKIN-12; MALARIA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PARASITEMIA; PLASMODIUM CHABAUDI; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 84888137927     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00923-13     Document Type: Article

References (77)

1. World Health Organization. 2012. World malaria report 2012. World Health Organization, Geneva, Switzerland.
2. Meding SJ, Langhorne J. 1991. CD4γT cells and B cells are necessary for the transfer of protective immunity to Plasmodium chabaudi chabaudi. Eur. J. Immunol. 21:1433-1438.
3. Simon-Haarhaus B, Langhorne J, Meding S. 1991. CD4+ T celldependent effector mechanisms important in the immune response to the erythrocytic stages of Plasmodium chabaudi chabaudi (AS). Behring Inst. Mitt. 94-98.
4. Langhorne J, Simon-Haarhaus B, Meding SJ. 1990. The role of CD4+ T cells in the protective immune response to Plasmodium chabaudi in vivo. Immunol. Lett. 25:101-107.
5. van der Heyde HC, Huszar D, Woodhouse C, Manning DD, Weidanz WP. 1994. The resolution of acute malaria in a definitive model of B cell deficiency, the JHD mouse. J. Immunol. 152:4557-4562.
6. Stephens R, Culleton RL, Lamb TJ. 2012. The contribution of Plasmodium chabaudi to our understanding of malaria. Trends Parasitol. 28:73-82.
7. van der Heyde HC, Manning DD, Roopenian DC, Weidanz WP. 1993. Resolution of blood-stage malarial infections in CD8+cell-deficient beta 2-m0/0 mice. J. Immunol. 151:3187-3191.
8. von der Weid T, Kitamura D, Rajewsky K, Langhorne J. 1994. A dual role for B cells in Plasmodium chabaudi chabaudi (AS) infection? Res. Immunol. 145:412-419.
9. von der Weid T, Honarvar N, Langhorne J. 1996. Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection. J. Immunol. 156:2510-2516.
10. Langhorne J, Cross C, Seixas E, Li C, von der Weid T. 1998. A role for B cells in the development of T cell helper function in a malaria infection in mice. Proc. Natl. Acad. Sci. U. S. A. 95:1730-1734.
11. Kasturi SP, Skountzou I, Albrecht RA, Koutsonanos D, Hua T, Nakaya HI, Ravindran R, Stewart S, Alam M, Kwissa M, Villinger F, Murthy N, Steel J, Jacob J, Hogan RJ, García-Sastre A, Compans R, Pulendran B. 2011. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470:543-547.
12. Hou B, Saudan P, Ott G, Wheeler ML, Ji M, Kuzmich L, Lee LM, Coffman RL, Bachmann MF, DeFranco AL. 2011. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity 34:375-384.
13. Stevenson MM, Riley EM. 2004. Innate immunity to malaria. Nat. Rev. Immunol. 4:169-180.
14. Su Z, Stevenson MM. 2002. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. J. Immunol. 168:1348-1355.
15. Riopel J, Tam M, Mohan K, Marino MW, Stevenson MM. 2001. Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria. Infect. Immun. 69:129-136.
16. Kim CC, Nelson CS, Wilson EB, Hou B, DeFranco AL, DeRisi JL. 2012. Splenic red pulp macrophages produce type I interferons as early sentinels of malaria infection but are dispensable for control. PLoS One 7:e48126. doi:10.1371/journal.pone.0048126.
17. Sponaas AM, Freitas do Rosario AP, Voisine C, Mastelic B, Thompson J, Koernig S, Jarra W, Renia L, Mauduit M, Potocnik AJ, Langhorne J. 2009. Migrating monocytes recruited to the spleen play an important role in control of blood stage malaria. Blood 114:5522-5531.
18. Belyaev NN, Brown DE, Diaz AI, Rae A, Jarra W, Thompson J, Langhorne J, Potocnik AJ. 2010. Induction of an IL7-R(+)c-Kit(hi) myelolymphoid progenitor critically dependent on IFN-gamma signaling during acute malaria. Nat. Immunol. 11:477-485.
19. Coban C, Ishii KJ, Uematsu S, Arisue N, Sato S, Yamamoto M, Kawai T, Takeuchi O, Hisaeda H, Horii T, Akira S. 2007. Pathological role of Toll-like receptor signaling in cerebral malaria. Int. Immunol. 19:67-79.
20. Sharma S, DeOliveira RB, Kalantari P, Parroche P, Goutagny N, Jiang Z, Chan J, Bartholomeu DC, Lauw F, Hall JP, Barber GN, Gazzinelli RT, Fitzgerald KA, Golenbock DT. 2011. Innate immune recognition of an AT-rich stem-loopDNAmotif in the Plasmodium falciparum genome. Immunity 35:194-207.
21. Piva L, Tetlak P, Claser C, Karjalainen K, Renia L, Ruedl C. 2012. Cutting edge: Clec9A+dendritic cells mediate the development of experimental cerebral malaria. J. Immunol. 189:1128-1132.
22. Druilhe P, Spertini F, Soesoe D, Corradin G, Mejia P, Singh S, Audran R, Bouzidi A, Oeuvray C, Roussilhon C. 2005. A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum. PLoS Med. 2:e344. doi:10.1371/journal.pmed.0020344.
23. Oliveira GA, Wetzel K, Calvo-Calle JM, Nussenzweig R, Schmidt A, Birkett A, Dubovsky F, Tierney E, Gleiter CH, Boehmer G, Luty AJF, Ramharter M, Thornton GB, Kremsner PG, Nardin EH. 2005. Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial. Infect. Immun. 73:3587-3597.
24. Polhemus ME, Remich SA, Ogutu BR, Waitumbi JN, Otieno L, Apollo S, Cummings JF, Kester KE, Ockenhouse CF, Stewart A, Ofori-Anyinam O, Ramboer I, Cahill CP, Lievens M, Dubois MC, Demoitie MA, Leach A, Cohen J, Ballou WR, Heppner DG, Jr. 2009 Evaluation of RTS, S/AS02A and RTS, S/AS01B in adults in a high malaria transmission area. PLoS One 4:e6465. doi:10.1371/journal.pone.0006465.
25. Janeway CA, Jr, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216.
26. Franklin BS, Rodrigues SO, Antonelli LR, Oliveira RV, Goncalves AM, Sales-Junior PA, Valente EP, Alvarez-Leite JI, Ropert C, Golenbock DT, Gazzinelli RT. 2007. MyD88-dependent activation of dendritic cells and CD4(+) T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria. Microbes Infect. 9:881-890.
27. Togbe D, Schofield L, Grau GE, Schnyder B, Boissay V, Charron S, Rose S, Beutler B, Quesniaux VFJ, Ryffel B. 2007. Murine cerebral malaria development is independent of toll-like receptor signaling. Am. J. Pathol. 170:1640-1648.
28. Lepenies B, Cramer JP, Burchard GD, Wagner H, Kirschning CJ, Jacobs T. 2008. Induction of experimental cerebral malaria is independent of TLR2/4/9. Med. Microbiol. Immunol. 197:39-44.
29. Gowda NM, Wu X, Gowda DC. 2012. TLR9 and MyD88 are crucial for the development of protective immunity to malaria. J. Immunol. 188:5073-5085.
30. Pichyangkul S, Yongvanitchit K, UKum-arb, Hemmi H, Akira S, Krieg AM, Heppner DG, Stewart VA, Hasegawa H, Looareesuwan S, Shanks GD, Miller RS. 2004. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J. Immunol. 172:4926-4933.
31. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, Uematsu S, Yamamoto M, Takeuchi O, Itagaki S, Kumar N, Horii T, Akira S. 2005. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201:19-25.
32. Coban C, Igari Y, Yagi M, Reimer T, Koyama S, Aoshi T, Ohata K, Tsukui T, Takeshita F, Sakurai K, Ikegami T, Nakagawa A, Horii T, Nuñez G, Ishii KJ, Akira S. 2010. Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9. Cell Host Microbe 7:50-61.
33. Parroche P, Lauw FN, Goutagny N, Latz E, Monks BG, Visintin A, Halmen KA, Lamphier M, Olivier M, Bartholomeu DC, Gazzinelli RT, Golenbock DT. 2007. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Tolllike receptor 9. Proc. Natl. Acad. Sci. U. S. A. 104:1919-1924.
34. Wu X, Gowda NM, Kumar S, Gowda DC. 2010. Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J. Immunol. 184:4338-4348.
35. Griffith JW, O'Connor C, Bernard K, Town T, Goldstein DR, Bucala R. 2007. Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host. J. Infect. Dis. 196:1553-1564.
36. Kordes M, Matuschewski K, Hafalla JCR. 2011. Caspase-1 activation of interleukin-1β (IL-1β) and IL-18 is dispensable for induction of experimental cerebral malaria. Infect. Immun. 79:3633-3641.
37. Krishnegowda G, Hajjar AM, Zhu J, Douglass EJ, Uematsu S, Akira S, Woods AS, Gowda DC. 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280:8606-8616.
38. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny S, Sutterwala FS, Flavell RA, Ghosh S, Sher A. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308:1626-1629.
39. Figueiredo RT, Fernandez PL, Mourao-Sa DS, Porto BN, Dutra FF, Alves LS, Oliveira MF, Oliveira PL, Graça-Souza AV, Bozza MT. 2007. Characterization of heme as activator of Toll-like receptor 4. J. Biol. Chem. 282:20221-20229.
40. Couper KN, Barnes T, Hafalla JCR, Combes V, Ryffel B, Secher T, Grau GE, Riley EM, de Souza JB. 2010. Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog. 6:e1000744. doi:10.1371/journal.ppat.1000744.
41. Barrera V, Skorokhod OA, Baci D, Gremo G, Arese P, Schwarzer E. 2011. Host fibrinogen stably bound to hemozoin rapidly activates monocytes via TLR-4 and CD11b/CD18-integrin: a new paradigm of hemozoin action. Blood 117:5674-5682.
42. Franklin BS, Ishizaka ST, Lamphier M, Gusovsky F, Hansen H, Rose J, Zheng W, Ataíde MA, de Oliveira RB, Golenbock DT, Gazzinelli RT. 2011. Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. Proc. Natl. Acad. Sci. U. S. A. 108:3689-3694.
43. Du X, Poltorak A, Wei Y, Beutler B. 2000. Three novel mammalian toll-like receptors: Gene structure, expression, and evolution. Eur. Cytokine Netw. 11:362-371.
44. Chuang TH, Ulevitch RJ. 2000. Cloning and characterization of a subfamily of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 11:372-378.
45. Diebold SS, Kaisho T, Hemmi H, Akira S, Reise Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of singlestranded RNA. Science 303:1529-1531.
46. Waisberg M, Tarasenko T, Vickers BK, Scott BL, Willcocks LC, Molina-Cruz A, Pierce MA, Huang C, Torres-Velez FJ, Smith KGC, Barillas-Mury C, Miller LH, Pierce SK, Bolland S. 2011. Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice. Proc. Natl. Acad. Sci. U. S. A. 108:1122-1127.
47. Smyth GK, Speed T. 2003. Normalization of cDNA microarray data. Methods 31:265-273.
48. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:5116-5121.
49. Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4:44-57.
50. Kim CC, Wilson EB, DeRisi JL. 2010. Improved methods for magnetic purification of malaria parasites and haemozoin. Malar. J. 9:17. doi:10.1186/1475-2875-9-17.
51. Monroe KM, McWhirter SM, Vance RE. 2010. Induction of type I interferons by bacteria. Cell. Microbiol. 12:881-890.
52. Bogdan C, Mattner J, Schleicher U. 2004. The role of type I interferons in non-viral infections. Immunol. Rev. 202:33-48.
53. Voisine C, Mastelic B, Sponaas AM, Langhorne J. 2010. Classical CD11c+ dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to Plasmodium chabaudi malaria. Int. J. Parasitol. 40:711-719.
54. Haque A, Best SE, Ammerdorffer A, Desbarrieres L, de Oca MM, Amante FH, de Labastida Rivera F, Hertzog P, Boyle GM, Hill GR, Engwerda CR. 2011. Type I interferons suppress CD4+ T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur. J. Immunol. 41:2688-2698.
55. Tabeta K, Hoebe K, Janssen EM, Du X, Georgel P, Crozat K, Mudd S, Mann N, Sovath S, Goode J, Shamel L, Herskovits AA, Portnoy DA, Cooke M, Tarantino LM, Wiltshire T, Steinberg BE, Grinstein S, Beutler B. 2006. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7:156-164.
56. Scheu S, Dresing P, Locksley RM. 2008. Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo. Proc. Natl. Acad. Sci. U. S. A. 105:20416-20421.
57. Casanova JL, Abel L, Quintana-Murci L. 2011. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu. Rev. Immunol. 29:447-491.
58. Belgnaoui SM, Paz S, Hiscott J. 2011. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr. Opin. Immunol. 23:564-572.
59. Schoenemeyer A, Barnes BJ, Mancl ME, Latz E, Goutagny N, Pitha PM, Fitzgerald KA, Golenbock DT. 2005. The interferon regulatory factor, IRF5, is a central mediator of Toll-like receptor 7 signaling. J. Biol. Chem. 280:17005-17012.
60. Bastos KRB, Barboza R, Elias RM, Sardinha LR, Grisotto MG, Marinho CRF, Amarante-Mendes GP, Alvarez JM, Lima MRD. 2002. Impaired macrophage responses may contribute to exacerbation of blood-stage Plasmodium chabaudi chabaudi malaria in interleukin-12-deficient mice. J. Interferon Cytokine Res. 22:1191-1199.
61. Cigel F, Batchelder J, Burns JM, Jr, Yañez D, van der Heyde H, Manning DD, Weidanz WP. 2003. Immunity to blood-stage murine malarial parasites is MHC class II dependent. Immunol. Lett. 89:243-249.
62. Hernandez-Valladares M, Naessens J, Musoke AJ, Sekikawa K, Rihet P, Ole-Moiyoi OK, Busher P, Iraqi FA. 2006. Pathology of Tnf-deficient mice infected with Plasmodium chabaudi adami 408XZ. Exp. Parasitol. 114:271-278.
63. Long GH, Chan BHK, Allen JE, Read AF, Graham AL. 2008. Blockade of TNF receptor 1 reduces disease severity but increases parasite transmission during Plasmodium chabaudi chabaudi infection. Int. J. Parasitol. 38:1073-1081.
64. Freitas do Rosário AP, Lamb T, Spence P, Stephens R, Lang A, Roers A, Muller W, O'Garra A, Langhorne J. 2012. IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J. Immunol. 188:1178-1190.
65. Reinhardt RL, Liang HE, Locksley RM. 2009. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat. Immunol. 10:385-393.
66. Bafica A, Santiago HC, Goldszmid R, Ropert C, Gazzinelli RT, Sher A. 2006. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 177:3515-3519.
67. Gazzinelli RT, Denkers EY. 2006. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat. Rev. Immunol. 6:895-906.
68. Petzke MM, Brooks A, Krupna MA, Mordue D, Schwartz I. 2009. Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J. Immunol. 183:5279-5292.
69. Schamber-Reis BLF, Petritus PM, Caetano BC, Martinez ER, Okuda K, Golenbock D, Scott P, Gazzinelli RT. 2013. UNC93B1 and nucleic acid-sensing Toll-like receptors mediate host resistance to infection with Leishmania major. J. Biol. Chem. 288:7127-7136.
70. Wyler DJ, Gallin JI. 1977. Spleen-derived mononuclear cell chemotactic factor in malaria infections: a possible mechanism for splenic macrophage accumulation. J. Immunol. 118:478-484.
71. Su Z, Stevenson MM. 2000. Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection. Infect. Immun. 68:4399-4406.
72. Kwiatkowski DP. 2005. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77:171-192.
73. Willcocks LC, Carr EJ, Niederer HA, Rayner TF, Williams TN, Yang W, Scott JAG, Urban BC, Peshu N, Vyse TJ, Lau YL, Lyons PA, Smith KGC. 2010. A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 107:7881-7885.
74. Shen N, Fu Q, Deng Y, Qian X, Zhao J, Kaufman KM, Wu YL, Yu CY, Tang Y, Chen JY, Yang W, Wong M, Kawasaki A, Tsuchiya N, Sumida T, Kawaguchi Y, Howe HS, Mok MY, Bang SY, Liu FL, Chang DM, Takasaki Y, Hashimoto H, Harley JB, Guthridge JM, Grossman JM, Cantor RM, Song YW, Bae SC, Chen S, Hahn BH, Lau YL, Tsao BP. 2010. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 107:15838-15843.
75. dos Santos BP, Valverde JV, Rohr P, Monticielo OA, Brenol JCT, Xavier RM, Chies JAB. 2012. TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from southern Brazil. Lupus 21:302-309.
76. Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, Flavell RA, Bolland S. 2007. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27:801-810.
77. Molokhia M, McKeigue P. 2006. Systemic lupus erythematosus: genes versus environment in high risk populations. Lupus 15:827-832.